Alterations of genes involving both the mitogen-activated protein kinase (MAPK) (RAS-RAF-MEK-ERK) pathway and p14ARF–MDM2–p53 network are important in cutaneous melanoma [1,2,3]. This evidence concerns the gene CDKN2A and cutaneous melanoma.